Cargando…

Combining Genetic Mutation and Expression Profiles Identifies Novel Prognostic Biomarkers of Lung Adenocarcinoma

MOTIVATION: Although several prognostic signatures for lung adenocarcinoma (LUAD) have been developed, they are mainly based on a single-omics data set. This article aims to develop a novel set of prognostic signatures by combining genetic mutation and expression profiles of LUAD patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yun, Liu, Fu, Hu, Xintong, He, Jiaxue, Jiang, Yanfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826273/ https://www.ncbi.nlm.nih.gov/pubmed/35153523 http://dx.doi.org/10.1177/1179554920966260

Ejemplares similares

Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma
por: Han, Liankui, et al.
Publicado: (2018)

Characteristics of Genomic Alterations in Pericardial Effusion of Advanced Non-small Cell Lung Cancer
por: He, Jiaxue, et al.
Publicado: (2022)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma
por: Li, Yang, et al.
Publicado: (2020)

Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2022)

A targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma
por: Shao, Di, et al.
Publicado: (2016)

RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma
por: Li, Hong‐Shuai, et al.
Publicado: (2023)

Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma
por: Zhao, Songchen, et al.
Publicado: (2023)

The RIPK family: expression profile and prognostic value in lung adenocarcinoma
por: Li, Guo, et al.
Publicado: (2022)

Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma
por: Li, Guofeng, et al.
Publicado: (2020)

Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinoma
por: Song, Yueqiang, et al.
Publicado: (2019)

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation
por: Fu, Jing, et al.
Publicado: (2021)

Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
por: Kim, Soo Mi, et al.
Publicado: (2010)

Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
por: Li, Baihui, et al.
Publicado: (2021)

Spondin2 is a new prognostic biomarker for lung adenocarcinoma
por: Yuan, Xiaopeng, et al.
Publicado: (2017)

Emerging genetic biomarkers in lung adenocarcinoma
por: Barbar, Jawad, et al.
Publicado: (2022)

Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma
por: Liu, Xinyan, et al.
Publicado: (2015)

Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma
por: Zhang, Weiguo, et al.
Publicado: (2018)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
por: Qian, Li, et al.
Publicado: (2022)

Construction of an STK11 Mutation and Immune-Related Prognostic Prediction Model in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2023)

Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes
por: Chang, Chia-Ching, et al.
Publicado: (2022)

Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung
por: He, Si-Yu, et al.
Publicado: (2019)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Comprehensive analysis to identify a novel PTEN-associated ceRNA regulatory network as a prognostic biomarker for lung adenocarcinoma
por: Xin, Rui, et al.
Publicado: (2022)

CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
por: Xiao, Dayong, et al.
Publicado: (2020)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

The use of Multidimensional Data to Identify the Molecular Biomarker for Pancreatic Ductal Adenocarcinoma
por: Zhuang, Liwei, et al.
Publicado: (2013)

Redox-associated messenger RNAs identify novel prognostic values and influence the tumor immune microenvironment of lung adenocarcinoma
por: Zhao, Chen, et al.
Publicado: (2023)

Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma
por: Chen, Qirui, et al.
Publicado: (2023)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma
por: Feng, Wei, et al.
Publicado: (2023)

The transcriptional landscape and mutational profile of lung adenocarcinoma
por: Seo, Jeong-Sun, et al.
Publicado: (2012)

hsa_circ_0000729, a potential prognostic biomarker in lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

RS1 gene is a novel prognostic biomarker for lung adenocarcinoma
por: Zhang, Tao, et al.
Publicado: (2022)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
por: Liu, Bo, et al.
Publicado: (2021)

Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis
por: Zang, Xiao, et al.
Publicado: (2015)

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1s61c9f203utqsg7npqe9srstf